Mylan Inc. received final FDA approval for a generic version of the heartburn drug Prilosec.
The U.S. Food and Drug Administration approved an abbreviated new drug application for omeprazole delayed-release capsules, 40 mg.
The capsules are approved for the treatment of peptic ulcers and gastroesophageal reflux disease.
Prilosec is made by AstraZeneca PLC. Prilosec has serious side effects.
Mylan's shares went up.